SCHEMBL7007991

SCHEMBL7007991

CCN(CC)c1ccc2c(c1)Oc1cc(N(CC)CC)ccc1N2C(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 5/20 0.56
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAOB P27338 1/20 0.44
MAPT P10636 2/20 0.43
CACNA1H O95180 1/20 0.43
CACNA1B Q00975 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CNR2 P34972 1/20 0.41
NOX1 Q9Y5S8 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29435150 1.00 P2RX4 (0.56) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL10617141 0.96 P2RX4 (0.63) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL9354682 0.93 P2RX4 (0.49) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL7190882 0.88 P2RX4 (0.41) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL389568 0.85 MEN1 (0.67) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL8924419 0.83 BCHE (0.46) P2RX4MEN1KMT2ACACNA1HCACNA1B
SCHEMBL13138312 0.82 CACNA1B (0.55) MEN1KMT2AMAPTCACNA1HCACNA1B
SCHEMBL5108199 0.82 KDM1A (0.42) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL9009797 0.82 MAPT (0.48) P2RX4MEN1KMT2AL3MBTL1MAPK1
SCHEMBL29386291 0.82 KMT2A (0.49) P2RX4MEN1KMT2AL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2919998-A1 COLOUR-FORMING MATERIALS, CONTACT RECORDING DEVICES AND PRESSURE RECORDING DEVICES Active Device Development Limited (GB) 2015-09-23 EP claimed
WO-2014076468-A1 COLOUR-FORMING MATERIALS, CONTACT RECORDING DEVICES AND PRESSURE RECORDING DEVICES ACTIVE DEVICE DEVELOPMENT LIMITED (GB) 2014-05-22 WO claimed
US-20030139293-A1 Heat sensitive recording material CIBA SPECIALTY CHEMICALS CORP. 2003-07-24 US claimed
EP-1268215-A1 HEAT SENSITIVE RECORDING MATERIAL Ciba SC Holding AG (CH) 2003-01-02 EP claimed
WO-2001072527-A1 HEAT SENSITIVE RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-10-04 WO claimed
EP-0159874-B1 PREVENTION OF SPOTTING IN THERMAL IMAGING COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-07-24 EP claimed
EP-4744902-A1 ON-PRESS DEVELOPMENT-TYPE PLANOGRAPHIC PRINTING PLATE PRECURSOR, PLANOGRAPHIC PRINTING PLATE PRODUCTION METHOD, AND PLANOGRAPHIC PRINTING METHO FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
EP-4744901-A1 ON-PRESS DEVELOPMENT TYPE PLANOGRAPHIC PRINTING PLATE ORIGINAL PLATE, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
US-20260131566-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
EP-4186708-B1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING A LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORP (JP) 2026-03-04 EP disclosed
EP-4438301-B1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORP (JP) 2025-11-05 EP disclosed
EP-3991988-B1 LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD FOR PREPARING A LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORP (JP) 2025-11-05 EP disclosed
WO-1981003642-A1 RECORD MATERIAL CARRYING A COLOUR DEVELOPER COMPOSITION WIGGINS TEAPE GROUP LTD (GB) 1981-12-24 WO disclosed
WO-1981003643-A1 RECORD MATERIAL CARRYING A COLOUR DEVELOPER COMPOSITION WIGGINS TEAPE GROUP LTD (GB) 1981-12-24 WO disclosed
EP-0042265-A1 Record material carrying a colour developer composition The Wiggins Teape Group Limited (GB) 1981-12-23 EP disclosed
EP-0042266-A1 Record material carrying a colour developer composition The Wiggins Teape Group Limited (GB) 1981-12-23 EP disclosed
US-4284696-A Light transmission particle for forming color image HODOGAYA CHEMICAL CO., LTD. (JP) 1981-08-18 US disclosed
US-4262078-A SUBLIMABLE COLOR-FORMING PYRIDINE DERIVATIVE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1981-04-14 US disclosed
US-4238562-A TRANSPARENT RESIN BINDER, SPIROBENZOPYRAN INDOLE, COLORING AGENT HODOGAYA CHEMICAL CO., LTD. (JP) 1980-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND LEF1, LARP1, RUVBL1 P2RX4 2401/4885MEN1 251/4885KMT2A 1817/4885
US-20260131566-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD LAMTOR3, LEF1, RER1 P2RX4 2213/4885MEN1 324/4885KMT2A 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.